Concepedia

Marielle Klein Hesselink

MK

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2024

Affiliations

King's College London(Current)

Marielle Klein Hesselink is an author at King's College London specializing in immune checkpoint combination therapy, immunotherapy, and synthetic long peptides.

Publications per year

2024–2024

1

Publications

1

Results of a randomized, double-blind, placebo-controlled, phase 2 study (OpcemISA) of the combination of ISA101b and cemiplimab versus cemiplimab for recurrent/metastatic (R/M) HPV16-positive oropharyngeal cancer (OPC).

Caroline Even, Kevin J. Harrington, Erminia Massarelli et al. · Journal of Clinical Oncology · 2024 · 15 citations

, , +13

1–1 of 1